Looking at the Major Trends in this Year’s MDEA Program

REDPIXEL - stock.adobe.com IMG_May72021at13648PM.jpg
From digital health products to COVID-19 solutions, MD+DI takes a look at some of the major trends in this year’s MDEA program.

COVID-19 and digital health are two subjects that loomed largely in this year’s Medical Design Excellence Awards (MDEA) Program.  The prestigious award program—recognizing cutting-edge achievements in medical product design since 1998— spans 11 categories and celebrates the Best in Show and MD+DI Readers' Choice. (For a complete list of finalists, please click here; to see past winners, click here.) 

With just a few days away from The Medtech Design Summit 2021, MD+DI is taking a deep dive into some of the trend-making products.

It would be an understatement to say that COVID-19 hasn’t had an impact. In healthcare much of the story is now about vaccination. But there is another component in healthcare that isn’t spoken about much now – testing.  Here are some of the devices and technologies that contribute to the trend.

S3 Connected Health has designed Enodatis, a web-based clinical support tool for respiratory care of COVID-19 patients.

S3 Connected Health, with help from senior respiratory consultants, created Enodatis in response to the urgent need for a solution that enables hospitals to optimize and scale acute respiratory care during the COVID-19 global pandemic.

 MediPines developed the AGM100, a non-invasive pulmonary gas exchange monitor that measures a patient's gas exchange. In a 90 second breathing test, it detects respiratory impairment caused by conditions such as COVID-19, COPD, and pneumonia and is used throughout the hospital including point-of-care triage in the ED and perioperative medicine.

Fluidigm has developed the Advanta Dx SARS-CoV-2 RT-PCR Assay, a non-invasive saliva-based COVID-19 test, which can rapidly produce results and has been instrumental in several testing solutions. The FDA submission demonstrated 100%  agreement between saliva results from the Fluidigm assay and results from paired nasopharyngeal samples tested with authorized assays.

Now onto digital health.

Theranica has developed Nerivio, a smartphone-controlled therapeutic wearable for the acute treatment of migraine, offers patients an effective, affordable, drug-free first-line alternative to traditional migraine medications, without compromising efficacy or safety. Worn on the upper arm, Nerivio wirelessly and remotely stimulates the body’s innate pain regulation mechanism to effectively mitigate pain.

Medtronic is bringing SmartSync, a tablet-based tool to clinicians. The technology can be used to input and change settings for heart device patients. SmartSync's exclusive design allows support from the control room rather than next to the patient (up to 38 feet away from the implanted heart device).

Glytec has developed Glucommander, which utilizes evidence-based multivariate algorithms to provide care teams with personalized computer-guided insulin dosing recommendations that continuously recalculate and dynamically calibrate dosing based on each individual patient’s blood glucose trends, insulin sensitivities, and response to therapy. Its safety and efficacy have been validated by more than 80 research studies.

For more information on the Medical Design Excellence Awards (MDEA) and the Medtech Design Summit 2021, please visit here.

 

TAGS: COVID-19
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish